This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dohlman CH, Schneider HA, Doane, MG. Prosthokeratoplasty. Am. J. Ophthalmol. 1974; 77: 694–700.DohlmanCHSchneiderHADoaneMGProsthokeratoplasty19747769470010.1016/0002-9394(74)90534-04596032Search in Google Scholar
Kitazawa K, Wakimasu K, Kayukawa K, Yokota I, Inatomi T, Hieda O, Sotozono C, Kinoshita S. Moderately long-term safety and efficacy of repeat penetrating keratoplasty. Cornea. 2018; 37: 1255–1259.KitazawaKWakimasuKKayukawaKYokotaIInatomiTHiedaOSotozonoCKinoshitaSModerately long-term safety and efficacy of repeat penetrating keratoplasty2018371255125910.1097/ICO.000000000000169430052560Search in Google Scholar
Srujana D, Kaur M, Urkude J, Rathi A, Sharma N, Titiyal JS. Long-term functional and anatomic outcomes of repeat graft after optically failed therapeutic keratoplasty. Am. J. Ophthalmol. 2018; 189: 166–175.SrujanaDKaurMUrkudeJRathiASharmaNTitiyalJSLong-term functional and anatomic outcomes of repeat graft after optically failed therapeutic keratoplasty201818916617510.1016/j.ajo.2018.03.01129550189Search in Google Scholar
Yildiz EH, Hoskins E, Fram N, Rapuano CJ, Hammersmith KM, Laibson PR, Cohen EJ. Third or greater penetrating keratoplasties: Indications, survival, and visual outcomes. Cornea. 2010; 29: 254–259.YildizEHHoskinsEFramNRapuanoCJHammersmithKMLaibsonPRCohenEJThird or greater penetrating keratoplasties: Indications, survival, and visual outcomes20102925425910.1097/ICO.0b013e3181b31b6f20118784Search in Google Scholar
Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, Kharashi SA, Jindan MA, Tandon R, Mascarenhas J, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012; 119: 1530–1538.AldaveAJSangwanVSBasuSBasakSKHovakimyanAGevorgyanOKharashiSAJindanMATandonRMascarenhasJInternational results with the Boston type I keratoprosthesis20121191530153810.1016/j.ophtha.2012.02.01522512986Search in Google Scholar
Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011; 118: 1543–1550.GreinerMALiJYMannisMJLonger-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis20111181543155010.1016/j.ophtha.2010.12.03221397948Search in Google Scholar
Priddy J, Bardan AS, Tawfik HS, Liu C. Systematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis. Cornea. 2019; 38: 1465–1473.PriddyJBardanASTawfikHSLiuCSystematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis2019381465147310.1097/ICO.000000000000209831403526Search in Google Scholar
Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2011; 30: 1187–1194.SejpalKYuFAldaveAJThe Boston keratoprosthesis in the management of corneal limbal stem cell deficiency2011301187119410.1097/ICO.0b013e318211446721885964Search in Google Scholar
Zerbe BL, Belin MW, Ciolino JB. Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006; 113: 1779.e1–7.ZerbeBLBelinMWCiolinoJBBoston Type 1 Keratoprosthesis Study GroupResults from the multicenter Boston Type 1 Keratoprosthesis Study20061131779.e1710.1016/j.ophtha.2006.05.01516872678Search in Google Scholar
Bostan C, Nayman T, Szigiato AA, Morfeq H, Harissi-Dagher M. Endophthalmitis in eyes with the Boston type I keratoprosthesis: Incidence, recurrence, risk factors, and outcomes. Cornea. 2021; 40: 1258–1266.BostanCNaymanTSzigiatoAAMorfeqHHarissi-DagherMEndophthalmitis in eyes with the Boston type I keratoprosthesis: Incidence, recurrence, risk factors, and outcomes2021401258126610.1097/ICO.000000000000264133394754Search in Google Scholar
Nascimento E, Silva R, Taniguchi EV, Cruzat A, Paschalis EI, Pasquale LR, Colby KA, Dohlman CH, Chodosh J, Shen LQ. Angle anatomy and glaucoma in patients with Boston keratoprosthesis. Cornea. 2020; 39: 713–719.NascimentoESilvaRTaniguchiEVCruzatAPaschalisEIPasqualeLRColbyKADohlmanCHChodoshJShenLQAngle anatomy and glaucoma in patients with Boston keratoprosthesis20203971371910.1097/ICO.000000000000221631764284Search in Google Scholar
Sayegh RR, Pineda R 2nd. Practical applications of anterior segment optical coherence tomography imaging following corneal surgery. Semin. Ophthalmol. 2012; 27: 125–132.SayeghRRPinedaR2ndPractical applications of anterior segment optical coherence tomography imaging following corneal surgery20122712513210.3109/08820538.2012.70727423163266Search in Google Scholar
Samy El Gendy NM, Li Y, Zhang X, Huang D. Repeatability of pachymetric mapping using fourier domain optical coherence tomography in corneas with opacities. Cornea. 2012; 31: 418–423.Samy El GendyNMLiYZhangXHuangDRepeatability of pachymetric mapping using fourier domain optical coherence tomography in corneas with opacities20123141842310.1097/ICO.0b013e31823f098c329982922236789Search in Google Scholar
Szalai E, Németh G, Hassan Z, Módis L Jr. Noncontact evaluation of corneal grafts: Swept-source Fourier domain OCT versus high-resolution Scheimpflug imaging. Cornea. 2017; 36: 434–439.SzalaiENémethGHassanZMódisLJrNoncontact evaluation of corneal grafts: Swept-source Fourier domain OCT versus high-resolution Scheimpflug imaging20173643443910.1097/ICO.000000000000113328079690Search in Google Scholar
Wylegała E, Teper S, Nowińska AK, Milka M, Dobrowolski D. Anterior segment imaging: Fourier-domain optical coherence tomography versus time-domain optical coherence tomography. J. Cataract Refract. Surg. 2009; 35: 1410–1414.WylegałaETeperSNowińskaAKMilkaMDobrowolskiDAnterior segment imaging: Fourier-domain optical coherence tomography versus time-domain optical coherence tomography2009351410141410.1016/j.jcrs.2009.03.03419631129Search in Google Scholar
Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II diagnostic methodology report. Ocul. Surf. 2017; 15: 539–574.WolffsohnJSAritaRChalmersRDjalilianADogruMDumbletonKGuptaPKKarpeckiPLazregSPultHTFOS DEWS II diagnostic methodology report20171553957410.1016/j.jtos.2017.05.00128736342Search in Google Scholar
Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003; 22: 640–650.BronAJEvansVESmithJAGrading of corneal and conjunctival staining in the context of other dry eye tests20032264065010.1097/00003226-200310000-0000814508260Search in Google Scholar
Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O’Brien T, Rolando M, Tsubota K, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol. Vis. Sci. 2011; 52: 2050–2064.GeerlingGTauberJBaudouinCGotoEMatsumotoYO’BrienTRolandoMTsubotaKNicholsKKThe international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction2011522050206410.1167/iovs.10-6997g307216321450919Search in Google Scholar
Ahmad S, Mathews PM, Srikumaran D, Aldave AJ, Lenis T, Aquavella JV, Hannush SB, Belin M, Akpek EK. Outcomes of repeat Boston type 1 keratoprosthesis implantation. Am. J. Ophthalmol. 2016; 161: 181–187.e1.AhmadSMathewsPMSrikumaranDAldaveAJLenisTAquavellaJVHannushSBBelinMAkpekEKOutcomes of repeat Boston type 1 keratoprosthesis implantation2016161181187.e110.1016/j.ajo.2015.10.01226482467Search in Google Scholar
Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, Jin YP, Cohen EJ. Boston keratoprosthesis outcomes and complications. Cornea. 2009; 28: 989–996.ChewHFAyresBDHammersmithKMRapuanoCJLaibsonPRMyersJSJinYPCohenEJBoston keratoprosthesis outcomes and complications20092898999610.1097/ICO.0b013e3181a186dc19724214Search in Google Scholar
Ciolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ. Boston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: Multicenter study results. Ophthalmology. 2013; 120: 1195–1200.CiolinoJBBelinMWTodaniAAl-ArfajKRudniskyCJBoston Keratoprosthesis Type 1 Study Group. Retention of the Boston keratoprosthesis type 1: Multicenter study results20131201195120010.1016/j.ophtha.2012.11.025367418823499061Search in Google Scholar
Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, et al. TFOS DEWS II management and therapy report. Ocul. Surf. 2017; 15: 575–628.JonesLDownieLEKorbDBenitez-Del-CastilloJMDanaRDengSXDongPNGeerlingGHidaRYLiuYTFOS DEWS II management and therapy report20171557562810.1016/j.jtos.2017.05.00628736343Search in Google Scholar
Kanu LN, Niparugs M, Nonpassopon M, Karas FI, de la Cruz JM, Cortina MS. Predictive factors of Boston type I keratoprosthesis outcomes: A long-term analysis. Ocul. Surf. 2020; 18: 613–619.KanuLNNiparugsMNonpassoponMKarasFIde la CruzJMCortinaMSPredictive factors of Boston type I keratoprosthesis outcomes: A long-term analysis20201861361910.1016/j.jtos.2020.07.01232702418Search in Google Scholar
Palioura S, Kim B, Dohlman CH, Chodosh J. The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea. 2013; 32: 956–961.PaliouraSKimBDohlmanCHChodoshJThe Boston keratoprosthesis type I in mucous membrane pemphigoid20133295696110.1097/ICO.0b013e318286fd7323538625Search in Google Scholar
Srikumaran D, Munoz B, Aldave AJ, Aquavella JV, Hannush SB, Schultze R, Belin M, Akpek EK. Long-term outcomes of Boston type 1 keratoprosthesis implantation: A retrospective multicenter cohort. Ophthalmology. 2014; 121: 2159–2164.SrikumaranDMunozBAldaveAJAquavellaJVHannushSBSchultzeRBelinMAkpekEKLong-term outcomes of Boston type 1 keratoprosthesis implantation: A retrospective multicenter cohort20141212159216410.1016/j.ophtha.2014.05.03025017414Search in Google Scholar
Magalhães FP, Hirai FE, de Sousa LB, de Oliveira LA. Boston type 1 keratoprosthesis outcomes in ocular burns. Acta Ophthalmol. 2013; 91: e432–e436.MagalhãesFPHiraiFEde SousaLBde OliveiraLABoston type 1 keratoprosthesis outcomes in ocular burns201391e432e43610.1111/aos.1208323406295Search in Google Scholar
Banitt M. Evaluation and management of glaucoma after keratoprosthesis. Curr. Opin. Ophthalmol. 2011; 22: 133–136.BanittMEvaluation and management of glaucoma after keratoprosthesis20112213313610.1097/ICU.0b013e328343723d21191292Search in Google Scholar
Kang JJ, Allemann N, Cruz Jde L, Cortina MS. Serial analysis of anterior chamber depth and angle status using anterior segment optical coherence tomography after Boston keratoprosthesis. Cornea. 2013; 32: 1369–1374.KangJJAllemannNCruzJde LCortinaMSSerial analysis of anterior chamber depth and angle status using anterior segment optical coherence tomography after Boston keratoprosthesis2013321369137410.1097/ICO.0b013e3182a0cff523974896Search in Google Scholar
Rudnisky CJ, Belin MW, Todani A, Al-Arfaj K, Ament JD, Zerbe BJ, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: Multicenter study results. Ophthalmology. 2012; 119: 951–955.RudniskyCJBelinMWTodaniAAl-ArfajKAmentJDZerbeBJCiolinoJBBoston Type 1 Keratoprosthesis Study GroupRisk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: Multicenter study results201211995195510.1016/j.ophtha.2011.11.030334321222361316Search in Google Scholar
Malhotra C, Dhingra D, Jain AK. Keratoprosthesis optic and carrier corneal graft “noncontact” as a cause of sterile stromal necrosis in a case of Auro KPro implantation. Indian J. Ophthalmol. 2019; 67: 685–686.MalhotraCDhingraDJainAKKeratoprosthesis optic and carrier corneal graft “noncontact” as a cause of sterile stromal necrosis in a case of Auro KPro implantation20196768568610.4103/ijo.IJO_1713_18649891031007242Search in Google Scholar
Poddar R, Cortés DE, Werner JS, Mannis MJ, Zawadzki RJ. Three-dimensional anterior segment imaging in patients with type 1 Boston keratoprosthesis with switchable full depth range swept source optical coherence tomography. J. Biomed. Opt. 2013; 18: 86002.PoddarRCortésDEWernerJSMannisMJZawadzkiRJThree-dimensional anterior segment imaging in patients with type 1 Boston keratoprosthesis with switchable full depth range swept source optical coherence tomography2013188600210.1117/1.JBO.18.8.086002373122723912759Search in Google Scholar
Shapiro BL, Cortés DE, Chin EK, Li JY, Werner JS, Redenbo E, Mannis MJ. High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis. Cornea. 2013; 32: 951–955.ShapiroBLCortésDEChinEKLiJYWernerJSRedenboEMannisMJHigh-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis20133295195510.1097/ICO.0b013e318285c8f4374109123591146Search in Google Scholar
Zarei-Ghanavati S, Betancurt C, Mas AM, Wang J, Perez VL. Ultra high resolution optical coherence tomography in Boston type I keratoprosthesis. J. Ophthalmic Vis. Res. 2015; 10: 26–32.Zarei-GhanavatiSBetancurtCMasAMWangJPerezVLUltra high resolution optical coherence tomography in Boston type I keratoprosthesis201510263210.4103/2008-322X.156092442471426005549Search in Google Scholar
Iyer G, Srinivasan B, Agarwal S, Talele D, Rishi E, Rishi P, Krishnamurthy S, Vijaya L, Subramanian N, Somasundaram S. Keratoprosthesis: Current global scenario and a broad Indian perspective. Indian J. Ophthalmol. 2018; 66: 620–629.IyerGSrinivasanBAgarwalSTaleleDRishiERishiPKrishnamurthySVijayaLSubramanianNSomasundaramSKeratoprosthesis: Current global scenario and a broad Indian perspective20186662062910.4103/ijo.IJO_22_18593915029676302Search in Google Scholar
Lee R, Khoueir Z, Tsikata E, Chodosh J, Dohlman CH, Chen TC. Long-term visual outcomes and complications of Boston keratoprosthesis type II implantation. Ophthalmology. 2017; 124: 27–35.LeeRKhoueirZTsikataEChodoshJDohlmanCHChenTCLong-term visual outcomes and complications of Boston keratoprosthesis type II implantation2017124273510.1016/j.ophtha.2016.07.01127538795Search in Google Scholar
Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al. TFOS DEWS II Epidemiology Report. Ocul. Surf. 2017; 15: 334–365.StapletonFAlvesMBunyaVYJalbertILekhanontKMaletFNaKSSchaumbergDUchinoMVehofJTFOS DEWS II Epidemiology Report20171533436510.1016/j.jtos.2017.05.00328736337Search in Google Scholar